Mechanisms of Tumor Immune Evasion Induced by Hypoxia and Potential Therapeutic Strategies
Overview
Hypoxia is a significant factor in tumor immune evasion, affecting both tumor behavior and immune cell function. This review discusses the mechanisms by which hypoxia alters the tumor microenvironment.
Background
Hypoxia is prevalent in solid tumors and contributes to immune escape by reshaping the tumor microenvironment. It affects the function of immune cells and promotes an immunosuppressive environment.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Hypoxia induces immune evasion by suppressing CD8+ T cells and natural killer cells.
HIF-1α and HIF-2α are key regulators of transcriptional programs that support tumor survival and immune suppression.
Hypoxia promotes the accumulation of regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells.
Metabolic changes driven by hypoxia, such as lactate accumulation and acidosis, create a hostile environment for effector immune cells.
RNA modifications like m6A and ac4C link hypoxia signaling with immune checkpoint regulation.
Targeting hypoxia-related pathways may enhance antitumor immunity, but combination therapies are likely necessary due to overlapping escape mechanisms.
Clinical Implications
Clinicians should consider the impact of hypoxia on tumor behavior and immune response.
Conclusion
Hypoxia plays a critical role in tumor immune evasion, and understanding its mechanisms is essential for developing effective therapeutic strategies. Future research should focus on integrating hypoxia modulation with existing cancer therapies.
